Phenotypic and Genotypic Studies in Congenital and Early Onset Ataxias (ATAXIC)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01488461|
Recruitment Status : Completed
First Posted : December 8, 2011
Last Update Posted : June 15, 2015
Congenital ataxias (CA) are rare, non progressive diseases, characterized by psychomotor retardation, hypotonia followed by ataxia. The presence of the "molar tooth" on MRI allowed to define Joubert syndrome, a peculiar form of CA. Apart from this group, CA are mostly associated with cerebellar atrophy or hypoplasia without molar tooth on MRI. CA are a clinically as well as genetically heterogeneous group of diseases. Early-onset ataxias are progressive but may be difficult to distinguish from CA in the first years of the disease. To date, few genes responsible for CA have been identified: ABC7 (X-linked CA associated with sideroblastic anemia), SLC9A6 (X-linked CA associated with severe mental retardation, autism and epilepsy), GPR56 (CA associated with polymicrogyria), ATCAY (pure CA in Cayman isolate); the involvement of the ATCAY and ABC7 genes has never been assessed in a large cohort of CA patients.
To assess the frequency of mutations of the ATCAY and ABC7 genes in patients affected with non Joubert congenital or early-onset ataxia.
To identify new loci and/or genes responsible for CA To further describe the clinical phenotype of the CA and to assess the frequency of the various clinical types (pure CA/CA associated with spasticity/ syndromic CA, congenital/early-onset CA, sporadic/familial CA).
To describe the clinical phenotype of CA related to mutations in one of analysed genes.
|Condition or disease||Intervention/treatment|
|Congenital Cerebellar Ataxias Early-onset Cerebellar Ataxias||Genetic: blood sample|
All patients will be examined by a geneticist or a neuropediatric. All clinical data will be collected.
Strategy of the molecular study :
- for all multiplex and consanguineous families a linkage analysis (loci ATCAY and ABC7 and others AC known genes) will be performed.
- For all sporadic patients as well as linked multiplex and consanguineous families : sequencing of all coding exons of the gene ATCAY and others AC known genes.
- For all sporadic male patients and linked families : sequencing of all coding exons of the gene ABC7.
- For all patients with suggestive features : sequencing of all coding exons of the gene GPR56, VLDLR, NHE6 or other candidate gene.
- In consanguineous families : linkage analysis using SNP-array and analysis of candidate genes present in the regions of extended homozygosity
- linkage analysis in dominant families and analysis of candidate genes in the linked regions.
- If a new AC locus is identified (using linkage or CGH array), this gene will be sequenced in all patients.
|Study Type :||Observational|
|Actual Enrollment :||165 participants|
|Official Title:||Phenotypic and Genotypic Studies in Congenital and Early Onset Ataxias|
|Study Start Date :||January 2012|
|Actual Primary Completion Date :||October 2014|
|Actual Study Completion Date :||October 2014|
Genetic: blood sample
Blood sample will be analysed in order to check presence or not of mutation in ABC7, SLC9A6, GPR56, ATCAY.
- Percentage of the patients with a mutation in one of the analysed genes. [ Time Frame: 1 day ]
- Percentage of patients with severe/moderate/mild/absent intellectual deficiency [ Time Frame: 1 day ]
- Percentage of patients with/without epilepsy/spasticity/extraneurological features and nature and frequency of MRI anomalies [ Time Frame: 1 day ]
Biospecimen Retention: Samples With DNA
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01488461
|Hôpital Trousseau, Service de Génétique|
|Paris, France, 75012|
|Principal Investigator:||Lydie Burglen, PhD||Assistance Publique|